# A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

> **NCT06805474** · — · RECRUITING · sponsor: **Nanoscope Therapeutics Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Macular Degeneration
- Geographic Atrophy
- Stargardt Disease

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT06805474
- **Lead sponsor:** Nanoscope Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-05-27
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06805474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06805474, "A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06805474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*